Zobrazeno 1 - 10
of 96
pro vyhledávání: '"N. N. Spirin"'
Autor:
N. S. Baranova, L. A. Ovsyannikova, Ya. S. Ostapenko, N. N. Spirin, A. A. Baranov, M. S. Gris, A. S. Artyukhov, Yu. V. Manyakina
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 0, Pp 57-64 (2024)
An imbalance in the production of proand anti-inflammatory cytokines plays an important role in the pathogenesis of multiple sclerosis (MS) and chronic neuroborreliosis (CNB).Objective: to perform a comparative analysis of cytokine production in pati
Externí odkaz:
https://doaj.org/article/3f151725433149fc967604ff11cf7b62
Autor:
T. O. Simaniv, K. Z. Bakhtiyarova, A. N. Belova, Z. A. Goncharova, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, T. N. Trushnikova, E. L. Turova, T. I. Khaibullin, M. A. Sherman, A. N. Boyko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 0, Pp 71-75 (2023)
Neuromyelitis optic spectrum disorders (NMOSD) are rare, severely disabling diseases of the central nervous system. They are characterized by periodic, unpredictable exacerbations that lead to an accumulation of irreversible neurologic damage. Despit
Externí odkaz:
https://doaj.org/article/298d9945790f4c46830ed8b7004d3aa3
Autor:
N. V. Zarubina, N. N. Spirin
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 3, Pp 41-47 (2023)
Multiple sclerosis (MS) is a neurodegenerative disease that leads to multiple focal and diffuse lesions of the central nervous system, resulting in disability of patients. Currently the impact of depression on the quality of life (QoL) of MS patients
Externí odkaz:
https://doaj.org/article/30131a8f732e4cd395d09dad0ea9a73f
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 1S, Pp 21-26 (2021)
To date, the features of clinical presentation, course, and the effectiveness of therapy for multiple sclerosis (MS) in the presence of persistent herpesvirus infection (PHVI) remain poorly understood.Objective: to evaluate the features of clinical p
Externí odkaz:
https://doaj.org/article/6b666a65947047a0bc2d9c8c8fab82b1
Autor:
N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 2, Pp 157-161 (2021)
The opinion of Russian experts on the possibility of COVID-19 vaccination in patients with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number of domestic and foreign guidelines, conclude that it
Externí odkaz:
https://doaj.org/article/160bfabe4e594d8393af8e0708c38546
Publikováno v:
Бюллетень сибирской медицины, Vol 18, Iss 4, Pp 127-135 (2020)
Objective: to study the probable laboratory predictors of aggressive multiple sclerosis.Materials and methods. Antibodies to myelin oligodendrocyte glycoprotein (MOG), antibodies to thyroperoxidase and markers of endothelial dysfunction in blood seru
Externí odkaz:
https://doaj.org/article/507bfffe26404a77877481ceb195feea
Autor:
N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 5, Pp 138-145 (2020)
The need for optimal treatment of the active forms of multiple sclerosis (MS), especially highly active MS (HAMS), poses a number of difficult problems for specialists, including not only the choice of a highly effective disease-modifying drug for MS
Externí odkaz:
https://doaj.org/article/5f178b23c350496eb61e04a1caa188bb
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 1S, Pp 44-47 (2020)
The main target for COVID-19 is the lung with the development of acute respiratory failure. But the virus also displays tropism to the central nervous, muscle, and immune systems. The paper gives the data available in the literature on nervous system
Externí odkaz:
https://doaj.org/article/69083f7588a1402b8fe8d5aa27604765
Autor:
K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 3, Pp 93-99 (2020)
Currently, special attention is paid to timely treatment for active forms of multiple sclerosis (MS), especially for highly active MS (HAMS), in which there are ≥2 exacerbations and corresponding activity signs that are detected by magnetic resonan
Externí odkaz:
https://doaj.org/article/c217e7ea7284465eb0e7a0d9c87eea84
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 11, Iss 4, Pp 166-171 (2019)
More than 10 multiple sclerosis-modifying drugs (MSMDs) are widely used now. Novel MSMDs should be investigated in strict accordance with the evidence-based medicine principles governing clinical trials (of both original drugs and their analogues) th
Externí odkaz:
https://doaj.org/article/543d13c7f39f40a5a77ad3ffddc25e81